APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $313,000 | -25.1% | 7,300 | 0.0% | 0.00% | – |
Q4 2020 | $418,000 | +90.0% | 7,300 | 0.0% | 0.00% | – |
Q3 2020 | $220,000 | +86.4% | 7,300 | +102.8% | 0.00% | – |
Q2 2020 | $118,000 | +76.1% | 3,600 | +44.0% | 0.00% | – |
Q1 2020 | $67,000 | +45.7% | 2,500 | +66.7% | 0.00% | – |
Q4 2019 | $46,000 | +27.8% | 1,500 | 0.0% | 0.00% | – |
Q3 2019 | $36,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |